Larvol Delta - Comparative-Efficacy-and-Safety-of-Upadacitinib-Versus-Deucravacitinib-in-BiologicNa239ve-Patients-with-Psoriatic-Arthritis-A-MatchingAdjusted-Indirect-Comparison

Rinvoq (upadacitinib) - AbbVie

Sotyktu (deucravacitinib) - BMS

https://acrconvergence2026.eventscribe.net/fsPopup.asp?PresentationID=1899384&mode=presInfo

Philip J. Mease, MD

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next